Tealwood Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Sell |
3,466
-83
| -2% | -$37K | 0.69% | 71 |
|
|
2025
Q1 | $1.72M | Sell |
3,549
-41
| -1% | -$19.9K | 0.8% | 54 |
|
|
2024
Q4 | $1.45M | Sell |
3,590
-23
| -0.6% | -$9.26K | 0.6% | 79 |
|
|
2024
Q3 | $1.68M | Buy |
+3,613
| New | +$1.68M | 0.74% | 61 |
|
|
2024
Q2 | – | Sell |
-4,379
| Closed | -$1.83M | – | 127 |
|
|
2024
Q1 | $1.83M | Buy |
4,379
+2
| +0% | +$836 | 0.82% | 47 |
|
|
2023
Q4 | $1.78M | Sell |
4,377
-92
| -2% | -$37.4K | 0.85% | 43 |
|
|
2023
Q3 | $1.55M | Buy |
4,469
+76
| +2% | +$26.4K | 0.8% | 49 |
|
|
2023
Q2 | $1.55M | Buy |
4,393
+9
| +0.2% | +$3.17K | 0.75% | 53 |
|
|
2023
Q1 | $1.38M | Sell |
4,384
-118
| -3% | -$37.2K | 0.7% | 58 |
|
|
2022
Q4 | $1.3M | Sell |
4,502
-67
| -1% | -$19.3K | 0.68% | 68 |
|
|
2022
Q3 | $1.32M | Sell |
4,569
-8,806
| -66% | -$2.55M | 0.71% | 54 |
|
|
2022
Q2 | $3.77M | Sell |
13,375
-627
| -4% | -$177K | 1.87% | 3 |
|
|
2022
Q1 | $3.65M | Sell |
14,002
-295
| -2% | -$77K | 1.55% | 5 |
|
|
2021
Q4 | $3.14M | Sell |
14,297
-595
| -4% | -$131K | 1.26% | 11 |
|
|
2021
Q3 | $2.7M | Buy |
+14,892
| New | +$2.7M | 1.09% | 21 |
|
|
2021
Q1 | $2.61M | Buy |
12,138
+6,103
| +101% | +$1.31M | 1.04% | 29 |
|
|
2020
Q4 | $1.43M | Buy |
6,035
+2,467
| +69% | +$583K | 0.67% | 56 |
|
|
2020
Q3 | $971K | Buy |
3,568
+1
| +0% | +$272 | 0.63% | 68 |
|
|
2020
Q2 | $1.04M | Buy |
+3,567
| New | +$1.04M | 0.69% | 57 |
|